These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 18664376

  • 1. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.
    Imbesi M, Uz T, Manev H.
    Neuroscience; 2008 Sep 09; 155(4):1160-4. PubMed ID: 18664376
    [Abstract] [Full Text] [Related]

  • 2. Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells.
    Imbesi M, Uz T, Dzitoyeva S, Manev H.
    Neurosci Lett; 2008 Jul 04; 439(1):34-6. PubMed ID: 18501512
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.
    Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Kawamata Y, Hinuma S, Miyamoto M.
    Neuropharmacology; 2005 Feb 04; 48(2):301-10. PubMed ID: 15695169
    [Abstract] [Full Text] [Related]

  • 5. Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis.
    Fink T, Glas M, Wolf A, Kleber A, Reus E, Wolff M, Kiefer D, Wolf B, Rensing H, Volk T, Mathes AM.
    Crit Care Med; 2014 Jan 04; 42(1):e22-31. PubMed ID: 24145838
    [Abstract] [Full Text] [Related]

  • 6. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.
    Juszczak M, Roszczyk M, Kowalczyk E, Stempniak B.
    J Physiol Pharmacol; 2014 Dec 04; 65(6):777-84. PubMed ID: 25554981
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Melatonin receptor type 1 signals to extracellular signal-regulated kinase 1 and 2 via Gi and Gs dually coupled pathways in HEK-293 cells.
    Chen L, He X, Zhang Y, Chen X, Lai X, Shao J, Shi Y, Zhou N.
    Biochemistry; 2014 May 06; 53(17):2827-39. PubMed ID: 24724723
    [Abstract] [Full Text] [Related]

  • 9. Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle.
    López-Canul M, Min SH, Posa L, De Gregorio D, Bedini A, Spadoni G, Gobbi G, Comai S.
    Int J Mol Sci; 2019 May 17; 20(10):. PubMed ID: 31108968
    [Abstract] [Full Text] [Related]

  • 10. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
    Fisher SP, Davidson K, Kulla A, Sugden D.
    J Pineal Res; 2008 Sep 17; 45(2):125-32. PubMed ID: 18298466
    [Abstract] [Full Text] [Related]

  • 11. Role of melatonin receptors in the effects of melatonin on BDNF and neuroprotection in mouse cerebellar neurons.
    Imbesi M, Uz T, Manev H.
    J Neural Transm (Vienna); 2008 Nov 17; 115(11):1495-9. PubMed ID: 18493705
    [Abstract] [Full Text] [Related]

  • 12. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
    Lucini V, Pannacci M, Scaglione F, Fraschini F, Rivara S, Mor M, Bordi F, Plazzi PV, Spadoni G, Bedini A, Piersanti G, Diamantini G, Tarzia G.
    J Med Chem; 2004 Aug 12; 47(17):4202-12. PubMed ID: 15293992
    [Abstract] [Full Text] [Related]

  • 13. Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.
    Nishiyama K, Shintani Y, Hirai K, Yoshikubo S.
    J Pharmacol Exp Ther; 2009 Sep 12; 330(3):855-63. PubMed ID: 19556449
    [Abstract] [Full Text] [Related]

  • 14. Ramelteon, a selective MT1/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells.
    Osanai K, Kobayashi Y, Otsu M, Izawa T, Sakai K, Iwashita M.
    Hum Cell; 2017 Jul 12; 30(3):209-215. PubMed ID: 28382516
    [Abstract] [Full Text] [Related]

  • 15. Melatonin receptor activation suppresses adrenocorticotropin production via BMP-4 action by pituitary AtT20 cells.
    Tsukamoto N, Otsuka F, Ogura-Ochi K, Inagaki K, Nakamura E, Toma K, Terasaka T, Iwasaki Y, Makino H.
    Mol Cell Endocrinol; 2013 Aug 15; 375(1-2):1-9. PubMed ID: 23701823
    [Abstract] [Full Text] [Related]

  • 16. [A novel therapeutic drug: ramelteon].
    Miyamoto M.
    Nihon Rinsho; 2009 Aug 15; 67(8):1595-600. PubMed ID: 19768947
    [Abstract] [Full Text] [Related]

  • 17. The melatonin receptor MT1 is required for the differential regulatory actions of melatonin on neuronal 'clock' gene expression in striatal neurons in vitro.
    Imbesi M, Arslan AD, Yildiz S, Sharma R, Gavin D, Tun N, Manev H, Uz T.
    J Pineal Res; 2009 Jan 15; 46(1):87-94. PubMed ID: 18798788
    [Abstract] [Full Text] [Related]

  • 18. Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro.
    Winczyk K, Fuss-Chmielewska J, Lawnicka H, Pawlikowski M, Karasek M.
    Neuro Endocrinol Lett; 2009 Jan 15; 30(5):657-62. PubMed ID: 20035258
    [Abstract] [Full Text] [Related]

  • 19. Evidence of the receptor-mediated influence of melatonin on pancreatic glucagon secretion via the Gαq protein-coupled and PI3K signaling pathways.
    Bähr I, Mühlbauer E, Albrecht E, Peschke E.
    J Pineal Res; 2012 Nov 15; 53(4):390-8. PubMed ID: 22672634
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of M-II, the major human metabolite of ramelteon.
    Nishiyama K, Nishikawa H, Kato K, Miyamoto M, Tsukamoto T, Hirai K.
    Pharmacology; 2014 Nov 15; 93(3-4):197-201. PubMed ID: 24923230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.